Israel Englander Kronos Bio, Inc. Put Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KRON
# of Institutions
8Shares Held
965KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY874KShares$769,2090.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ12KShares$10,5890.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.66KShares$1,4630.0% of portfolio
-
Dakota Community Bank & Trust Na Hebron, ND943Shares$8290.0% of portfolio
-
Jpmorgan Chase & CO New York, NY441Shares$3880.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $50M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...